Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Ketamine for Post-operative Analgesia in Hemorrhoidectomy
University of Oklahoma
Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation
Naveen Poonai
Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
National Institute of Mental Health (NIMH)
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
National Institute of Allergy and Infectious Diseases (NIAID)
Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery
Göteborg University
Premedication for Less Invasive Surfactant Administration
University of Oulu
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
University Hospital, Basel, Switzerland
Anesthetics and Analgesics in Children
Chi Dang Hornik
Measuring Analgesic Interventions
Julia Finkel
Ketamine Enhances Analgesia and Mood in Chronic Pain Patients
Salem Anaesthesia Pain Clinic
Dexmedetomidine and Ketamine in VATS Surgery
Ciusss de L'Est de l'Île de Montréal
ECT with Ketamine Anesthesia Vs High Intensity Ketamine with ECT Rescue for Treatment-Resistant Depression
University of Saskatchewan
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
National Institute of Mental Health (NIMH)
The Neurobiological Effect of 5-HT2AR Modulation
Gitte Moos Knudsen
Imaging SV2A in Mood Disorders
Yale University
Neurobiology of Suicide
National Institute of Mental Health (NIMH)
Ketamine Alcohol (in Treatment-Resistant Depression)
Mark Niciu
National Pregnancy Registry for Psychiatric Medications
Massachusetts General Hospital
Safety Profile of Psilocybin for Cocaine Use Disorder
University of California, Los Angeles
Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)
University of Wisconsin, Madison
Ketamine for Sedation in Severe Traumatic Brain Injury
Henry M. Jackson Foundation for the Advancement of Military Medicine
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Texas A&M University
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Wake Forest University Health Sciences
An Investigation of Psilocybin on Behavioural and Cognitive Symptoms of Adults With Fragile X Syndrome
Nova Mentis Life Science Corp
Testing the Effectiveness of Cognitive Training Among Depressed Patients Receiving Esketamine Treatment
University of Pittsburgh
Glutamatergic Mechanisms: Aim2
New York State Psychiatric Institute
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
PharmaTher Inc.
IM Ketamine vs Midazolam for Suicidal ER Patients
New York State Psychiatric Institute
Glutamatergic Mechanisms of Psychosis and Target Engagement (SA1)
New York State Psychiatric Institute
Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion
Dr. Marie Eve Sophie Bussiere-Cote
Ketamine Versus Electroconvulsive Therapy in Depression
University of Ottawa
A Study of Human Multi-Sensory Integration
University of Pennsylvania
Ketamine vs Propofol for Sedation During Pediatric Bronchoscopy
Rabin Medical Center
Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study
OrthoCarolina Research Institute, Inc.
Systemic Ketamine for the Improvement of Post-Operative Analgesia at the Alcohol-Dependent Patient
University Hospital, Clermont-Ferrand
Role Of Non-Specific Effects in The Treatment of Depression With Esketamine
Yale University
Ketamine for OUD and Suicidal Ideation in the ED
Brigham and Women's Hospital
Behavioural Activation Therapy and Esketamine for Resistant Depression
The Royal's Institute of Mental Health Research
Ketamine-assisted Therapy for Advanced GI Cancer
Brian Anderson, MD
Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers
University of Utah
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
GH Research Ireland Limited
Phase 2 Clinical Trial of GH001 in Postpartum Depression
GH Research Ireland Limited
[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine
National Institute of Mental Health (NIMH)
Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression
Zylorion Health
Ketamine Pilot Study
Meghan Spyres
Ketamine Infusion for Rapid Reduction of Suicidality in Pediatrics
University of British Columbia
Low-dose KETamine as an Adjunct to MOrphine for Acute Pain in the ED
University of Aarhus
The Using Postoperative Ketamine and Exploring the Effect on Endometriosis Pain (UPKEEEP) Study
NYU Langone Health
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.